Analyst Reco. Harmonic Inc.

Equities

HLIT

US4131601027

Real-time Estimate Cboe BZX Other stock markets 15:17:35 01/05/2024 BST			5-day change	1st Jan Change
11.04 ^USD	+2.79%		+18.29%	-14.46%

04-30	Harmonic Breaks Even in Q1, Revenue Falls; Sets Q2, 2024 Outlooks -- Shares Up After Hours	MT
04-29	Transcript : Harmonic Inc., Q1 2024 Earnings Call, Apr 29, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating	01-30	MT
Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating	01-30	MT
Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating	11-01	MT
Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15	10/08/23	MT
Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating	01/08/23	MT
Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating	01/08/23	MT
Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating	01/08/23	MT
Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating	01/08/23	MT
Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating	01/08/23	MT
Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating	09/05/23	MT
Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating	09/05/23	MT
Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating	21/03/23	MT
Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating	31/01/23	MT
Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating	31/01/23	MT
North American Morning Briefing : Stocks Seen Down as Rate Decisions Loom	31/01/23	DJ
Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating	24/01/23	MT
Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19	09/01/23	MT
LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform	16/12/22	MT
Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34	16/12/22	MT
Jefferies Downgrades Third Harmonic Bio to Hold From Buy, Slashes Price Target to $3.60 From $30	16/12/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Harmonic Inc.

Equities

HLIT

US4131601027

Analyst Reco.

Filters